Viewing nowCombinationAIDAPHACITADUO Tablet 10/100 mg
Sitagliptin Phosphate Hydrate 128.5mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Ahn-Gook Pharmaceutical Co., Ltd.

MFDS item code 202300306 · Approved 2023.01.19 · Insurance code 650206000
Improvement of blood glucose control in patients with type 2 diabetes
This medication helps patients with type 2 diabetes achieve better blood sugar control. Sitagliptin and dapagliflozin work together to complement dietary and exercise regimens. This effectively lowers blood sugar levels and aids in diabetes management. It is prescribed according to the patient's health condition, making it safe for use. Consistent use in conjunction with lifestyle improvements significantly contributes to diabetes management. This medication improves blood sugar control in patients with type 2 diabetes.
This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. No dose adjustment is required if the estimated glomerular filtration rate [estimated glomerular filtration rate (eGFR)] is 45 mL/min/1.73m2 or more. This medicine should not be administered if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73 m2. No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication may cause allergic reactions; if symptoms of hypersensitivity such as skin rash, difficulty breathing, or swelling of the face or neck appear after administration, discontinue use immediately and consult a healthcare professional. This medication can cause serious inflammation of the pancreas known as pancreatitis; if symptoms like abdominal pain, vomiting, or nausea occur, inform a doctor immediately. This medication should not be used in patients with allergies to certain components or in those with type 1 diabetes or diabetic ketoacidosis, or undergoing dialysis. Patients with impaired kidney function, those with fluid depletion, elderly patients, and those taking diuretics should use this medication with caution, and renal function, blood pressure, and fluid status should be carefully checked before and after administration. This medication may increase the risk of genital and urinary tract infections; appropriate treatment should be sought if symptoms of infection (pain, itching, discharge, etc.) occur. There is a risk of hypoglycemia; especially when taken with other antidiabetic medications such as insulin or sulfonylureas, blood sugar changes should be closely monitored, and medication dosage adjusted if necessary. Pregnant or breastfeeding women should not use this medication, and if pregnancy is confirmed, administration should be discontinued immediately. During treatment, symptoms of dehydration or hypotension may occur, necessitating adequate fluid intake and blood pressure management. If any abnormal symptoms or discomfort persist while taking the medication, consult a healthcare professional for appropriate measures.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. Ideally, it should be kept at room temperature between 1°C and 30°C.
Yellow to orange, biconvex, round film-coated tablet
28 tablets/box [7 tablets (Alu-Alu) X 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Phosphate Hydrate 128.5mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Ahn-Gook Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.